Steris

STE

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding

In their latest 13F (Q3 2026)

See who

Value held

$20k

Combined value at quarter end

Last quarter

1 bought

0 sold or trimmed

Price at Q2 ’26 end

$210.58

-4.8% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

-12.8%Q1 ’26

-4.8%Q2 ’26

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

0Q4 ’23

0Q1 ’24

0Q2 ’24

0Q3 ’24

0Q4 ’24

0Q1 ’25

0Q2 ’25

0Q3 ’25

1Q4 ’25

1Q1 ’26

1Q2 ’26

0Q3 ’26

Counts the managers on this site whose 13F for that quarter includes Steris.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Steris

First Eagle Investment Management	0.0%$20k	$20k	Added +428%	3 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works

From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.

Sort by

Insider purchases and sales of Steris
		Bought or sold				Filing
12 Aug 2026	Sohi MohsenDirector	▼ Sold	4,058	$235.78	$957k	Form 4

About the company

Sector: Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated in: Ireland
Financial year ends: 31 March
Shares outstanding: 98m at 27 May 2026
SEC filings: Annual reports and other filings on EDGAR

Revenue and profit

$2.6bnMar ’17

$2.6bnMar ’18

$2.8bnMar ’19

$3.0bnMar ’20

$3.1bnMar ’21

$4.2bnMar ’22

$4.5bnMar ’23

$5.1bnMar ’24

$5.5bnMar ’25

$5.9bnMar ’26

Steris revenue and net income by year
Year	Revenue	Net income
Year to Mar 2026	$5.9bn	$782m
Year to Mar 2025	$5.5bn	$615m
Year to Mar 2024	$5.1bn	$378m
Year to Mar 2023	$4.5bn	$107m
Year to Mar 2022	$4.2bn	$244m
Year to Mar 2021	$3.1bn	$397m
Year to Mar 2020	$3.0bn	$408m
Year to Mar 2019	$2.8bn	$304m
Year to Mar 2018	$2.6bn	$291m
Year to Mar 2017	$2.6bn	$110m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.